Search

everythinglearnresearchcommunity

for

Search:↓

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Women with PCOS often have more sleep problems than the general population.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hair loss doesn't affect COVID-19 severity.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Women with PCOS often feel anxious and distressed about their appearance, especially in social situations.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Antiepileptic drugs can cause cosmetic side effects and affect menstrual cycles, fertility, and bone health in women with epilepsy.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Skin issues might be linked to infertility.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.